Reverse Voxsplaining: Drugs vs. Chairs | Slate Star Codex
[Content note: this is pretty much a rehash of things I’ve said before, and that other people have addressed much more eloquently. My only excuse for wasting your time with it again is that SOMEHOW THE MESSAGE STILL HASN’T SUNK IN. Pitching this as “market” vs. “government” is overly simplistic, but maybe if I am overly simplistic sometimes then it will sink in better.] EpiPens, useful medical devices which reverse potentially fatal allergic reactions, have recently quadrupled in price, putting pressure on allergy sufferers and those who care for them. Vox writes that this “tells us a lot about what’s wrong with American health care” – namely that we don’t regulate it enough: The story of Mylan’s giant EpiPen price increase is, more fundamentally, a story about America’s unique drug pricing policies. We are the only developed nation that lets drugmakers set their own prices, maximizing profits the same way sellers of chairs, mugs, shoes, or any other manufactured goods would. Let me as
[Content note: this is pretty much a rehash of things I’ve said before, and that other people have addressed much more eloquently. My only excuse for wasting your time with it again is that SOMEHOW THE MESSAGE STILL HASN’T SUNK IN. Pitching this as “market” vs. “government” is overly simplistic, but maybe if I am overly simplistic sometimes then it will sink in better.] EpiPens, useful medical devices which reverse potentially fatal allergic reactions, have recently quadrupled in price, putting pressure on allergy sufferers and those who care for them. Vox writes that this “tells us a lot…
related reading
- Reverse Voxsplaining: Brand-Name Drugs | Slate Star Codexslatestarcodex.com
- The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
- Why are our medicines so expensive? Spoiler: Not for the reasons you are being told… - PMCncbi.nlm.nih.gov
- The Ozempocalypse Is Nigh - by Scott Alexanderastralcodexten.com
- Inside the Mafia of Pharma Pricing - BIG by Matt Stollerthebignewsletter.com
- Why kid-friendly medications can be expensive for parentspbs.org
- Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharmacheekypint.substack.com
- 392: Someone Else's Money - This American Lifethisamericanlife.org
- Pharma Virumque | Slate Star Codexslatestarcodex.com
- TrumpRxtrumprx.gov
- Why the FDA Is Slow to Remove Drugspress.asimov.com
- How PBMs can use private-labelled drug products as a great escape from anti-steering policies - 46brooklyn Research46brooklyn.com